 |
 |

Dopamine in Drug Abuse and AddictionResults of Imaging Studies and Treatment Implications
Nora D. Volkow, MD;
Joanna S. Fowler, PhD;
Gene-Jack Wang, MD;
James M. Swanson, PhD;
Frank Telang, MD
Arch Neurol. 2007;64(11):1575-1579.
Imaging studies have provided new insights on the role of dopamine (DA) in drug abuse and addiction in the human brain. These studies have shown that the reinforcing effects of drugs of abuse in human beings are contingent not just on DA increases per se in the striatum (including the nucleus accumbens) but on the rate of DA increases. The faster the increases, the more intense the reinforcing effects. They have also shown that elevated levels of DA in the dorsal striatum are involved in the motivation to procure the drug when the addicted subject is exposed to stimuli associated with the drug (conditioned stimuli). In contrast, long-term drug use seems to be associated with decreased DA function, as evidenced by reductions in D2 DA receptors and DA release in the striatum in addicted subjects. Moreover, the reductions in D2 DA receptors in the striatum are associated with reduced activity of the orbitofrontal cortex (region involved with salience attribution and motivation and with compulsive behaviors) and of the cingulate gyrus (region involved with inhibitory control and impulsivity), which implicates deregulation of frontal regions by DA in the loss of control and compulsive drug intake that characterizes addiction. Because DA cells fire in response to salient stimuli and facilitate conditioned learning, their activation by drugs will be experienced as highly salient, driving the motivation to take the drug and further strengthening conditioned learning and producing automatic behaviors (compulsions and habits).
Author Affiliations: National Institute on Drug Abuse (Dr Volkow) and National Institute on Alcohol Abuse and Alcoholism (Drs Volkow and Telang), Bethesda, Maryland; Medical Department, Brookhaven National Laboratory, Upton, New York (Drs Fowler and Wang); and Department of Pediatrics, University of California, Irvine (Dr Swanson).
CiteULike Connotea Delicious Digg Facebook Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Pharmacokinetics and central nervous system effects of the novel dopamine D3 receptor antagonist GSK598809 and intravenous alcohol infusion at pseudo-steady state
te Beek et al.
J Psychopharmacol 2012;26:303-314.
ABSTRACT
| FULL TEXT
Molecular Mechanism for a Gateway Drug: Epigenetic Changes Initiated by Nicotine Prime Gene Expression by Cocaine
Levine et al.
Sci Transl Med 2011;3:107ra109-107ra109.
ABSTRACT
| FULL TEXT
Acute Cocaine Induces Fast Activation of D1 Receptor and Progressive Deactivation of D2 Receptor Striatal Neurons: In Vivo Optical Microprobe [Ca2+]i Imaging
Luo et al.
J. Neurosci. 2011;31:13180-13190.
ABSTRACT
| FULL TEXT
Colloquium Paper: Markov model of smoking cessation
Killeen
Proc. Natl. Acad. Sci. USA 2011;108:15549-15556.
ABSTRACT
| FULL TEXT
Adolescent Smokers Show Decreased Brain Responses to Pleasurable Food Images Compared With Nonsmokers
Rubinstein et al.
Nicotine Tob Res 2011;13:751-755.
ABSTRACT
| FULL TEXT
Neural Correlates of Food Addiction
Gearhardt et al.
Arch Gen Psychiatry 2011;68:808-816.
ABSTRACT
| FULL TEXT
Rewarding, Stimulant, and Sedative Alcohol Responses and Relationship to Future Binge Drinking
King et al.
Arch Gen Psychiatry 2011;68:389-399.
ABSTRACT
| FULL TEXT
Influence of Compulsivity of Drug Abuse on Dopaminergic Modulation of Attentional Bias in Stimulant Dependence
Ersche et al.
Arch Gen Psychiatry 2010;67:632-644.
ABSTRACT
| FULL TEXT
Dopamine, Reward, and Frontostriatal Circuitry in Impulse Control Disorders in Parkinson's Disease: Insights from Functional Imaging
Ray and Strafella
Clin EEG Neurosci 2010;41:87-93.
ABSTRACT
| FULL TEXT
Which Cue to "Want?" Central Amygdala Opioid Activation Enhances and Focuses Incentive Salience on a Prepotent Reward Cue
Mahler and Berridge
J. Neurosci. 2009;29:6500-6513.
ABSTRACT
| FULL TEXT
Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study
Steeves et al.
Brain 2009;132:1376-1385.
ABSTRACT
| FULL TEXT
Methylphenidate-induced dendritic spine formation and {Delta}FosB expression in nucleus accumbens
Kim et al.
Proc. Natl. Acad. Sci. USA 2009;106:2915-2920.
ABSTRACT
| FULL TEXT
Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology
Volkow et al.
Phil Trans R Soc B 2008;363:3191-3200.
ABSTRACT
| FULL TEXT
|